55 related articles for article (PubMed ID: 23038779)
1. Role of CRD-BP in the growth of human basal cell carcinoma cells.
Noubissi FK; Kim T; Kawahara TN; Aughenbaugh WD; Berg E; Longley BJ; Athar M; Spiegelman VS
J Invest Dermatol; 2014 Jun; 134(6):1718-1724. PubMed ID: 24468749
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Bell JL; Wächter K; Mühleck B; Pazaitis N; Köhn M; Lederer M; Hüttelmaier S
Cell Mol Life Sci; 2013 Aug; 70(15):2657-75. PubMed ID: 23069990
[TBL] [Abstract][Full Text] [Related]
3. IGF2BPs as novel m
Duan M; Liu H; Xu S; Yang Z; Zhang F; Wang G; Wang Y; Zhao S; Jiang X
Genes Dis; 2024 Mar; 11(2):890-920. PubMed ID: 37692485
[TBL] [Abstract][Full Text] [Related]
4. The Functional Roles and Regulation of Circular RNAs during Cellular Stresses.
Lee YC; Wang WY; Lin HH; Huang YR; Lin YC; Hsiao KY
Noncoding RNA; 2022 May; 8(3):. PubMed ID: 35736635
[TBL] [Abstract][Full Text] [Related]
5. Differential Oxygenation in Tumor Microenvironment Modulates Macrophage and Cancer Cell Crosstalk: Novel Experimental Setting and Proof of Concept.
Campillo N; Falcones B; Otero J; Colina R; Gozal D; Navajas D; Farré R; Almendros I
Front Oncol; 2019; 9():43. PubMed ID: 30788287
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C-α is upregulated by IMP1 in melanoma and is linked to poor survival.
Mahapatra L; Andruska N; Mao C; Gruber SB; Johnson TM; Fullen DR; Raskin L; Shapiro DJ
Melanoma Res; 2019 Oct; 29(5):539-543. PubMed ID: 30543563
[TBL] [Abstract][Full Text] [Related]
7. IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors.
Müller S; Bley N; Glaß M; Busch B; Rousseau V; Misiak D; Fuchs T; Lederer M; Hüttelmaier S
Nucleic Acids Res; 2018 Jul; 46(12):6285-6303. PubMed ID: 29660014
[TBL] [Abstract][Full Text] [Related]
8. A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation.
Mahapatra L; Andruska N; Mao C; Le J; Shapiro DJ
Transl Oncol; 2017 Oct; 10(5):818-827. PubMed ID: 28846937
[TBL] [Abstract][Full Text] [Related]
9. TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF.
Seberg HE; Van Otterloo E; Loftus SK; Liu H; Bonde G; Sompallae R; Gildea DE; Santana JF; Manak JR; Pavan WJ; Williams T; Cornell RA
PLoS Genet; 2017 Mar; 13(3):e1006636. PubMed ID: 28249010
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant-binding protein (CRD-BP).
Goswami S; Tarapore RS; Poenitzsch Strong AM; TeSlaa JJ; Grinblat Y; Setaluri V; Spiegelman VS
J Biol Chem; 2015 Jan; 290(1):384-95. PubMed ID: 25414259
[TBL] [Abstract][Full Text] [Related]
11. Control of cell migration through mRNA localization and local translation.
Liao G; Mingle L; Van De Water L; Liu G
Wiley Interdiscip Rev RNA; 2015; 6(1):1-15. PubMed ID: 25264217
[TBL] [Abstract][Full Text] [Related]
12. Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer.
Liu X; Ye H; Li L; Li W; Zhang Y; Zhang JY
J Immunol Res; 2014; 2014():326593. PubMed ID: 24872956
[TBL] [Abstract][Full Text] [Related]
13. Assessing specific oligonucleotides and small molecule antibiotics for the ability to inhibit the CRD-BP-CD44 RNA interaction.
King DT; Barnes M; Thomsen D; Lee CH
PLoS One; 2014; 9(3):e91585. PubMed ID: 24622399
[TBL] [Abstract][Full Text] [Related]
14. High-throughput fluorescence anisotropy screen for inhibitors of the oncogenic mRNA binding protein, IMP-1.
Mahapatra L; Mao C; Andruska N; Zhang C; Shapiro DJ
J Biomol Screen; 2014 Mar; 19(3):427-36. PubMed ID: 24108120
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the mRNA binding protein CRD-BP in the regulation of metastatic melanoma cell proliferation and invasion by hypoxia.
Craig EA; Weber JD; Spiegelman VS
J Cell Sci; 2012 Dec; 125(Pt 24):5950-4. PubMed ID: 23038779
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions.
Mills CN; Joshi SS; Niles RM
Mol Cancer; 2009 Nov; 8():104. PubMed ID: 19919690
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching.
Widmer DS; Hoek KS; Cheng PF; Eichhoff OM; Biedermann T; Raaijmakers MIG; Hemmi S; Dummer R; Levesque MP
J Invest Dermatol; 2013 Oct; 133(10):2436-2443. PubMed ID: 23474946
[TBL] [Abstract][Full Text] [Related]
19. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.
Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
Anticancer Res; 2003; 23(3A):2179-83. PubMed ID: 12894594
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
